{"id":"https://genegraph.clinicalgenome.org/r/031ec734-2612-49a8-93f2-529b49cfa770v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *SAT1* gene encodes diamine acetyltransferase 1, a rate-limiting enzyme that catalyzes the acetylation of polyamines and is involved in the conversion of spermidine and spermine to putrescine (PMIDs: 8500690, 27698118). *SAT1* was first reported in relation to X-linked recessive pediatric systemic lupus erythematosus (SLE) in 2022 (Xu et al., PMID: 35977808). \n\nGenetic evidence reviewed in the curation of this gene-disease relationship included 2 hemizygous variants (p.Asp40Tyr and p.Glu92Leufs*6) identified in 4 males diagnosed with childhood-onset SLE (PMID: 35977808). The mechanism of pathogenicity appears to be loss of function.\n \nThe gene-disease relationship is also supported by experimental evidence. A knock-in mouse model in which both hemizygous male and homozygous female mice carry the p.Glu92Leufs\\*6 frameshift variant in Sat1 develops pathologies resembling SLE (PMID: 35977808). Functional alteration assays using neutrophils isolated from the mouse model show that the p.Glu92Leufs*6 variant causes spontaneous NETosis and autophagy defects (PMID: 35977808). Decreased plasma levels of spermidine and  spermine are observed in SLE populations as compared to healthy controls (PMIDs: 29308729, 35977808).  \n\nIn summary, there is **limited** evidence to support the relationship between *SAT1* and pediatric systemic lupus erythematosus. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Monogenic Systemic and Incomplete Lupus Erythematosus GCEP on the meeting date June 14, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/031ec734-2612-49a8-93f2-529b49cfa770","GCISnapshot":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10123","date":"2024-06-14T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10123","date":"2025-02-28T04:13:18.783Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abc53f42-a22f-4cac-930b-c710857a258e","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc628f84-8681-4b2b-afaf-072e2f3fd523","type":"Finding","dc:description":"This mouse model develops typical features of SLE (autoantibodies, kidney disorder).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35977808","rdfs:label":"Sat1 KI mice have pathologies resembling SLE","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e44a626-e431-48a8-b9ce-5f698f5e8536","type":"EvidenceLine","dc:description":"The functional alteration data came also from the mouse model.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c3ab2a0-9700-4171-9b65-b371901836cc","type":"FunctionalAlteration","dc:description":"SAT1 is enriched in neutrophils. Bone marrow (BM)-isolated Sat1p.Glu92Leufs*6 neutrophils show spontaneous NETosis and autophagy defect.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35977808","rdfs:label":"Defective functions of bone marrow (BM)-isolated neutrophils"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.25},{"id":"https://genegraph.clinicalgenome.org/r/51dc331c-64d2-4d0d-885a-54f1a4dab232_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd93d9f3-023e-4b86-83dd-791d947eb56e","type":"EvidenceLine","dc:description":"Only one proband from the family Xu Case #B.2 will be scored. The evidence would otherwise be overweighted.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd93d9f3-023e-4b86-83dd-791d947eb56e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies show variant interferes with SAT1 mRNA and protein expression as well as enzyme activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dd93d9f3-023e-4b86-83dd-791d947eb56e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35977808","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1aeb197-6e30-4ca4-9980-2680a667e633","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002970.4(SAT1):c.272_273dup (p.Glu92LeufsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695231890"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6ee49666-129e-4080-941e-a92a654b366c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ee49666-129e-4080-941e-a92a654b366c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies show variant interferes with SAT1 mRNA and protein expression as well as enzyme activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6ee49666-129e-4080-941e-a92a654b366c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35977808","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1aeb197-6e30-4ca4-9980-2680a667e633"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/49c9e088-f00e-4db1-bfaa-5ca30ec5f79d","type":"EvidenceLine","dc:description":"Transcripts are predicted but not fully proven to be deleterious (~30% exon 2 skipped, 30% intron 2 retention and 40% normally spliced Tyr40-containing transcripts).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49c9e088-f00e-4db1-bfaa-5ca30ec5f79d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies demonstrated that the p.Asp40Tyr variant caused two additional aberrantly spliced SAT1 transcripts.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/49c9e088-f00e-4db1-bfaa-5ca30ec5f79d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35977808","allele":{"id":"https://genegraph.clinicalgenome.org/r/798fc138-a54c-4907-9202-5de23eea3db5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002970.4(SAT1):c.118G>T (p.Asp40Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA326922043"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/cc2f2efa-d4c7-49f4-b86e-00730756b84d","type":"EvidenceLine","dc:description":"Only one proband from the family Xu Case #A.1 will be scored. The evidence would otherwise be overweighted.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc2f2efa-d4c7-49f4-b86e-00730756b84d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies demonstrated that the p.Asp40Tyr variant caused two additional aberrantly spliced SAT1 transcripts.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cc2f2efa-d4c7-49f4-b86e-00730756b84d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35977808","allele":{"id":"https://genegraph.clinicalgenome.org/r/798fc138-a54c-4907-9202-5de23eea3db5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.25}],"evidenceStrength":"Limited","sequence":10037,"specifiedBy":"GeneValidityCriteria10","strengthScore":4.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/8HPkQ8A6Flg","type":"GeneValidityProposition","disease":"obo:MONDO_0019725","gene":"hgnc:10540","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_51dc331c-64d2-4d0d-885a-54f1a4dab232-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}